Abstract.
We report the case of a 4-month-old boy presenting with a giant cutaneous haemangioma complicated by Kasabach-Merritt syndrome (KMS) with severe thrombocytopenia. After poor response to corticosteroid therapy and subsequent treatment with interferon alpha-2a, radiotherapy led to tumour regression and resolution of the disseminated intravascular coagulopathy over a 14-month period of follow up. Whereas the various available treatment options are reviewed and discussed in this article, the therapy of choice should be chosen individually. Conclusion: to date prospective randomised and controlled trials are required to investigate the optimal management of patients with Kasabach-Merritt syndrome.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Frevel, T., Rabe, H., Ückert, F. et al. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review. Eur J Pediatr 161, 243–246 (2002). https://doi.org/10.1007/s00431-002-0953-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-002-0953-5